pretty mediocre. Good to see new arr for q3 and q4 ramping up. Adjusted ebitda (which excludes the 2mil pa run rate share phased payments as well as capitalised r&d) positive q4... well they better hope so. I don’t imagine they’ll want to drop below 4-5mil cash. They’ll be cutting it fine to make cash flow breakeven though, and I can’t imagine the market will re rate this higher until the threat of more dilution abates.
still think this will be a long term winner, but the path there could be rocky.
anyone know much about the new ceo?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
8.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $121.7M | |||
| Open | High | Low | Value | Volume |
| 8.4¢ | 8.4¢ | 8.3¢ | $35.97K | 430.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1583924 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.4¢ | 2803039 | 2 |
View Market Depth
| Last trade - 15.44pm 17/06/2025 (20 minute delay) ? |
| EVS (ASX) Chart |